Clinical trials for Cervical / Vulvar / Vaginal cancer

39 currently recruiting clinical trials
Phase 1 / Phase 2 Lung cancer Colon cancer Rectal cancer Liver and bile duct cancer Bladder / Urinary Tract / Urethral cancer Cervical / Vulvar / Vaginal cancer #NCT07169734 #2025-521441-24-00
NSCLC (Non-Small Cell Lung Cancer) Cervical cancer Squamous NSCLC Adenocarcinoma Intrahepatic cholangiocarcinoma Urothelial carcinoma Squamous cell carcinoma Locally Advanced Metastatic 1 2
1 recruiting site
Alentis Therapeutics AG
Phase 1 / Phase 2 Kidney cancer Pancreas cancer Liver and bile duct cancer Bladder / Urinary Tract / Urethral cancer Stomach and esophageal cancer Endometrial cancer Head and neck cancer Sarcoma and GIST Thymus cancer Penile cancer and germ cell tumors Cervical / Vulvar / Vaginal cancer #NCT05592626 #2023-505334-10-00
Locally Advanced Metastatic MSI/dMMR 1 2 3 or more
Systemic Treatment-Naive
5 recruiting sites
Marengo Therapeutics, Inc.
Phase 1 / Phase 2 Breast cancer Lung cancer Prostate cancer Colon cancer Rectal cancer Anal cancer Kidney cancer Pancreas cancer Liver and bile duct cancer Bladder / Urinary Tract / Urethral cancer Stomach and esophageal cancer Endometrial cancer Ovarian / Fallopian tubes / Peritoneum cancer Head and neck cancer Sarcoma and GIST Thymus cancer Penile cancer and germ cell tumors Cervical / Vulvar / Vaginal cancer #NCT06128551
Phase 1b extension de dose et phase 2 cohortes tumeurs solides naïves d'inhibiteurs de KRAS G12C
Locally Advanced Metastatic Metastatic Castration-resistant KRAS G12C 1 2 3 or more
Systemic Treatment-Naive Targeted therapy
7 recruiting sites
Revolution Medicines, Inc.
Phase 1 / Phase 2 Breast cancer Lung cancer Prostate cancer Colon cancer Rectal cancer Anal cancer Kidney cancer Pancreas cancer Liver and bile duct cancer Bladder / Urinary Tract / Urethral cancer Stomach and esophageal cancer Endometrial cancer Ovarian / Fallopian tubes / Peritoneum cancer Head and neck cancer Sarcoma and GIST Thymus cancer Penile cancer and germ cell tumors Cervical / Vulvar / Vaginal cancer #NCT06128551
Phase 1b Escalade de dose
Locally Advanced Metastatic Metastatic Castration-resistant KRAS G12C 1 2 3 or more
Systemic Treatment-Naive
7 recruiting sites
Revolution Medicines, Inc.
Phase 1 / Phase 2 Lung cancer Stomach and esophageal cancer Head and neck cancer Cervical / Vulvar / Vaginal cancer #NCT06747585 #2024-515459-39-00
NSCLC (Non-Small Cell Lung Cancer) Esophagus Cervical cancer Squamous NSCLC Squamous cell carcinoma Locally Advanced Metastatic 1 2 3 or more
Systemic Treatment-Naive
6 recruiting sites
Alentis Therapeutics AG
Phase 1 / Phase 2 Breast cancer Lung cancer Prostate cancer Kidney cancer Pancreas cancer Liver and bile duct cancer Bladder / Urinary Tract / Urethral cancer Endometrial cancer Ovarian / Fallopian tubes / Peritoneum cancer Head and neck cancer Thymus cancer Penile cancer and germ cell tumors Cervical / Vulvar / Vaginal cancer #NCT05768139 #2023-000442-41
Cohortes autres tumeurs solides
Oral cavity Nasopharynx Oropharynx Hypopharynx Larynx Nasal cavities and sinuses Squamous cell carcinoma HR Positive Locally Advanced Metastatic PIK3CA 1 2 3 or more
4 recruiting sites
Eli Lilly et compagnie
Phase 1 Cervical / Vulvar / Vaginal cancer #NCT05983432 #2023-506539-14-00
Cohorte cancer du col de l'utérus
Cervical cancer Locally Advanced Metastatic 1 Chemotherapy
Systemic Treatment-Naive
4 recruiting sites
SystImmune Inc.
Phase 1 Breast cancer Lung cancer Prostate cancer Colon cancer Rectal cancer Anal cancer Kidney cancer Pancreas cancer Liver and bile duct cancer Bladder / Urinary Tract / Urethral cancer Stomach and esophageal cancer Endometrial cancer Ovarian / Fallopian tubes / Peritoneum cancer Head and neck cancer Sarcoma and GIST Thymus cancer Penile cancer and germ cell tumors Cervical / Vulvar / Vaginal cancer #NCT06781983
Locally Advanced Metastatic Other mutation 1 2 3 or more
Systemic Treatment-Naive
2 recruiting sites
Innate Pharma
Phase 1 Breast cancer Lung cancer Colon cancer Rectal cancer Pancreas cancer Endometrial cancer Ovarian / Fallopian tubes / Peritoneum cancer Cervical / Vulvar / Vaginal cancer #NCT06400472 #2024-511238-11-00
NSCLC (Non-Small Cell Lung Cancer) Epithelial ovarian cancer Fallopian tube cancer Primary peritoneal cancer (PPC) Cervical cancer HER2 Negative HR Negative 1 2 3 or more
Systemic Treatment-Naive
3 recruiting sites
Eli Lilly et compagnie
Phase 1 Breast cancer Lung cancer Prostate cancer Colon cancer Rectal cancer Anal cancer Kidney cancer Pancreas cancer Liver and bile duct cancer Bladder / Urinary Tract / Urethral cancer Stomach and esophageal cancer Endometrial cancer Ovarian / Fallopian tubes / Peritoneum cancer Head and neck cancer Sarcoma and GIST Thymus cancer Penile cancer and germ cell tumors Cervical / Vulvar / Vaginal cancer #NCT06533059 #2024-515391-12-00
Locally Advanced Metastatic AKT 1 2 3 or more
BRAF HRAS KRAS G12C KRAS non G12C NRAS KRAS G12D Systemic Treatment-Naive
4 recruiting sites
Alterome Therapeutics, Inc.